CN103119060A - 治疗阿尔兹海默病的方法 - Google Patents

治疗阿尔兹海默病的方法 Download PDF

Info

Publication number
CN103119060A
CN103119060A CN2011800454649A CN201180045464A CN103119060A CN 103119060 A CN103119060 A CN 103119060A CN 2011800454649 A CN2011800454649 A CN 2011800454649A CN 201180045464 A CN201180045464 A CN 201180045464A CN 103119060 A CN103119060 A CN 103119060A
Authority
CN
China
Prior art keywords
antibody
leu
pro
ala
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011800454649A
Other languages
English (en)
Chinese (zh)
Inventor
奥列格·伊里奇·爱泼斯坦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44863153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN103119060(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from RU2010130353/15A external-priority patent/RU2542445C2/ru
Priority claimed from RU2011127058/15A external-priority patent/RU2536232C2/ru
Application filed by Individual filed Critical Individual
Publication of CN103119060A publication Critical patent/CN103119060A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN2011800454649A 2010-07-21 2011-07-15 治疗阿尔兹海默病的方法 Pending CN103119060A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
RU2010130353 2010-07-21
RU2010130353/15A RU2542445C2 (ru) 2010-07-21 2010-07-21 Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера
RU2011127058 2011-07-01
RU2011127058/15A RU2536232C2 (ru) 2011-07-01 2011-07-01 Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера
PCT/IB2011/002434 WO2012010978A2 (en) 2010-07-21 2011-07-15 A method of treating alzheimer's disease

Publications (1)

Publication Number Publication Date
CN103119060A true CN103119060A (zh) 2013-05-22

Family

ID=44863153

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011800454649A Pending CN103119060A (zh) 2010-07-21 2011-07-15 治疗阿尔兹海默病的方法

Country Status (16)

Country Link
US (1) US20130058982A1 (enExample)
EP (1) EP2596021A2 (enExample)
JP (1) JP2013535445A (enExample)
CN (1) CN103119060A (enExample)
AU (1) AU2011281252A1 (enExample)
CA (1) CA2805943A1 (enExample)
DE (1) DE112011102409T5 (enExample)
EA (1) EA029399B1 (enExample)
FR (1) FR2962912A1 (enExample)
GB (1) GB2496801B (enExample)
IT (1) ITTO20110633A1 (enExample)
MX (1) MX2013000808A (enExample)
NZ (1) NZ606969A (enExample)
PH (1) PH12013500143A1 (enExample)
UA (1) UA107836C2 (enExample)
WO (1) WO2012010978A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104324359A (zh) * 2014-09-25 2015-02-04 中山大学 Rry三肽在制备治疗阿尔茨海默症药物中的用途

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
EP2593474A2 (en) 2010-07-15 2013-05-22 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
DE112011102349T5 (de) 2010-07-15 2013-04-18 Oleg Iliich Epshtein Pharmazeutische Zusammensetzung und Behandlungsverfahren
CZ2013105A3 (cs) * 2010-07-15 2013-05-22 Iliich Epshtein@Oleg Zpusob zvýsení úcinku aktivované potencované formy protilátky
WO2012010970A2 (en) 2010-07-21 2012-01-26 Oleg Iliich Epshtein A method of treating attention deficit hyperactivity disorder
BR112013001296A2 (pt) * 2010-07-21 2017-12-19 Lliich Epshtein Oleg composições farmacêuticas e respectivo uso e métodos de tratamento de vertigem de diferentes origens, cinetose e distonia vascular vegetativa
RU2013111961A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111962A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101437489A (zh) * 2006-04-13 2009-05-20 米丽娅·德阿莫里姆 顺势疗法组合物及其试剂盒
US20100166762A1 (en) * 2000-06-20 2010-07-01 Oleg Iliich Epshtein Method of treating a pathological syndrome

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
RU2156621C1 (ru) 1999-03-04 2000-09-27 Эпштейн Олег Ильич Нейротропное лекарственное средство
AU2002258518A1 (en) * 2001-03-14 2002-09-24 Millennium Pharmaceuticals, Inc. Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
US6451547B1 (en) * 2001-04-25 2002-09-17 Syn X Pharma Process for differential diagnosis of Alzheimer's dementia and device therefor
UA76639C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76641C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
JP2006516089A (ja) * 2002-10-02 2006-06-22 ジェネンテック・インコーポレーテッド 腫瘍の診断と治療のための組成物と方法
TWI345470B (en) 2003-03-14 2011-07-21 Nutrition Res Inc Homeopathic formulations useful for treating pain and/or inflammation
BR112013001296A2 (pt) * 2010-07-21 2017-12-19 Lliich Epshtein Oleg composições farmacêuticas e respectivo uso e métodos de tratamento de vertigem de diferentes origens, cinetose e distonia vascular vegetativa

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100166762A1 (en) * 2000-06-20 2010-07-01 Oleg Iliich Epshtein Method of treating a pathological syndrome
CN101437489A (zh) * 2006-04-13 2009-05-20 米丽娅·德阿莫里姆 顺势疗法组合物及其试剂盒

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AIJING SHANG，ET AL.: "Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy", 《THE LANCET》, vol. 366, no. 9487, 27 August 2005 (2005-08-27), pages 726 - 732 *
T. A. VORONINA，ET AL: "Effect of Ultralow Doses of Antibodies to S-100 Protein in Animals with Impaired Cognitive Function and Disturbed Emotional and Neurological Status under Conditions of Experimental Alzheimer Disease", 《BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE》, vol. 148, no. 3, 30 September 2009 (2009-09-30), XP055018795, DOI: doi:10.1007/s10517-010-0757-y *
苗建亭等: "Alzheimer病形成过程中NO/ NOS机制的实验研究", 《第四军医大学学报》, vol. 22, no. 16, 31 August 2001 (2001-08-31) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104324359A (zh) * 2014-09-25 2015-02-04 中山大学 Rry三肽在制备治疗阿尔茨海默症药物中的用途

Also Published As

Publication number Publication date
DE112011102409T5 (de) 2013-07-04
AU2011281252A1 (en) 2013-03-07
NZ606969A (en) 2015-08-28
GB201302929D0 (en) 2013-04-03
EA029399B1 (ru) 2018-03-30
WO2012010978A3 (en) 2012-04-26
PH12013500143A1 (en) 2019-09-02
GB2496801A (en) 2013-05-22
GB2496801B (en) 2018-04-11
EA201300130A1 (ru) 2013-12-30
EP2596021A2 (en) 2013-05-29
UA107836C2 (uk) 2015-02-25
ITTO20110633A1 (it) 2012-01-22
CA2805943A1 (en) 2012-01-26
MX2013000808A (es) 2013-10-28
JP2013535445A (ja) 2013-09-12
WO2012010978A2 (en) 2012-01-26
FR2962912A1 (fr) 2012-01-27
US20130058982A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
CN103119060A (zh) 治疗阿尔兹海默病的方法
US8637030B2 (en) Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
US20120258146A1 (en) Method of treating organic diseases of nervous system, pschoorganic syndrome and encephalopathy
CN103119061A (zh) 治疗注意力不足过动症的方法
CN103124742A (zh) 药物组合物和治疗方法
US20160251448A1 (en) Method of increasing the effect of an activated-potentiated form of an antibody
RU2536234C2 (ru) Нейротропное лекарственное средство и способ лечения органических заболеваний нервной системы, психоорганического синдрома и энцефалопатий различного генеза
RU2500427C2 (ru) Лекарственное средство для лечения функциональных нарушений желудочно-кишечного тракта и способ лечения функциональных нарушений желудочно-кишечного тракта
RU2542445C2 (ru) Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера
CN103108657A (zh) 提高活性强化形式的抗体的效果的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130522